SUNDAY, JUNE 25, 2017

Synthetic flu vaccine can be delivered as nasal spray

A team of scientists in Adelaide, South Australia, has developed a new synthetic flu vaccine that is delivered as a nasal spray and may be effective against multiple strains of influenza, including strains A and B. Read More »

"Trojan Horse" vaccine may aid in fight against TB and malaria

Researchers from the University of Notre Dame recently co-authored a study that points to a potential breakthrough in the fight against both tuberculosis and malaria. Read More »

Myanmar announces mass polio vaccination plan

After a seven-month-old baby was diagnosed with polio, the first case in three years in Myanmar, the country has announced a mass vaccination. Read More »

Nanoparticles may be able to carry synthetic vaccines

A group of engineers at the Massachusetts Institute of Technology have designed a new type of nanoparticle that can carry synthetic versions of virus proteins that will elicit an immune response as strong as live virus vaccines. Read More »

Tropical seaweed may hold antimalarial properties

Researchers from the Georgia Institute of Technology have found that a group of chemical compounds used by a species of tropical seaweed to stop fungus attacks through chemical communication may have promising antimalarial properties for humans. Read More »

Gene makes African American more susceptible to TB

A mutated gene found in the immune system significantly increases the risk of developing tuberculosis for African Americans who carry the tuberculosis bacteria, according to a new study. Read More »

Venezuela contains cholera outbreak

The Venezuelan government recently announced that it has contained a cholera outbreak that at one time had sickened hundreds of people. Read More »

North Carolina records 18 deaths this flu season

Officials from the North Carolina Division of Public Health have confirmed that there have been 18 total deaths linked to the flu in the state this season, with most of the deaths coming in individuals who were not vaccinated. Read More »

Vaccine breakthrough may protect against deadly form of pneumonia

Researchers at Yeshiva University's Albert Einstein College of Medicine in New York have created an experimental vaccine that protects against a common and especially deadly form of pneumococcal pneumonia by using a synthetic replacement of a toxin-produc Read More »

Mutated H1N1 virus found in Japan

A five-year-old patient in Japan has been found to have a genetic mutation of the H1N1 influenza A virus that proved to be resistant to the well-known anti-influenza drug Rapiacta. Read More »

Nanoparticle could aid in long-lasting immunities

Scientists at the Emory Vaccine Center have designed tiny nanoparticles that may hold the secrets of long-lasting immunity. Read More »

Supreme Court upholds National Childhood Vaccine Injury Act of 1986

The National Childhood Vaccine Injury Act of 1986, which was recently brought up in a lower court to re-evaluate the validity of lawsuits brought by parents who claims their children were harmed by vaccinations, has been upheld. Read More »

More than 21,000 in U.S. caught whooping cough in 2010

According to U.S. health officials, over 21,000 people in the United States were infected with whooping cough in 2010, which represents the highest number of cases since 2005. Read More »

Genetically altered mosquitoes could end malaria

A group of researchers at the University of California-Davis Read More »

Chembio receives grant for rapid TB test

Chembio Diagnostics, Inc., has received a three year, $2.9 million small business innovative research phase II grant from the United States Nation Institutes of Health to continue developing a rapid serological test for active tuberculosis. Read More »

Supply problems expected for several vaccines

Supply problems are expected for some vaccines in the coming months, but it does not look like these problems will have an effect on the overall availability of any single vaccine, according to a recent report. Read More »

Boston officials work to contain measles case

Boston area health officials recently worked to keep an isolated measles case from becoming an outbreak. Read More »

Emergent BioSolutions, Inc., showcases TB vaccine

A joint delegation of members of the European Parliament and representatives from the Oxford-Emergent Tuberculosis Consortium recently visited Emergent BioSolutions, Inc.'s advanced tuberculosis vaccine trial site. Read More »

Travelers may have been exposed to measles

Public health officials are warning travelers and workers who were present at four major U.S. airports that they may have been exposed to the measles virus from someone arriving from London. Read More »

Biotechnology firm awarded grant to develop malaria vaccine

The Rockville, Maryland-based biotechnology firm Sanaria has been awarded a three year, $3 million phase II small business research innovation grant from the National Institutes of Health to continue developing a vaccine that protects against malaria. Read More »